RNA, U6 small nuclear 785, pseudogene (RNU6-785P)

RNU6-785P is a processed pseudogene derived from the U6 small nuclear RNA gene (U6 snRNA), which is an essential component of the spliceosome responsible for splicing pre-mRNA in eukaryotic cells[1][3]. Unlike canonical U6 snRNA, which has a highly conserved sequence and critical catalytic function in RNA splicing[1][3], pseudogenes like RNU6-785P typically lack the ability to encode functional RNA or protein. Many RNA-derived pseudogenes are transcribed at low levels in a tissue-specific manner[2]. Some can produce small RNAs with regulatory potential, such as interference or modulation of parental gene expression, and may contribute to epigenetic regulation[2]. However, most pseudogenes, including RNU6-785P, are not recognized as direct therapeutic targets, biomarkers, or safety risks and do not encode functional protein or catalytic RNA. There is ongoing research into the broader role of transcribed RNA pseudogenes in cell biology and disease, including their hypothesized function as competing endogenous RNAs (ceRNAs) which may affect the abundance or regulation of microRNAs and, thereby, parental gene expression[2]. No drugs or clinical diagnostic assays specifically target RNU6-785P. It should be classified as a non-coding RNA-derived pseudogene—part of genome annotation but not a conventional drug target.

Other names

RNU6-785PU6 small nuclear RNA pseudogeneU6 snRNA pseudogene 785

None (no drugs known to act on RNU6-785P)